It's down to us. We have been bad. We have dropped our level. Maybe we have lacked concentration in moments and it's cost us. And tiredness as well. So tiredness I think is the biggest factor, but we ...
Barcelona winger, Raphinha has warned his teammates against putting up the wrong mindset during games. The Brazilian urged them to adopt a winning mentality to help them fight for trophies in the ...
And I had my tubes and ovaries removed very soon after my diagnosis of BRCA2, no regrets, no second guessing." Now, Brystowski recommends everyone look into genetic testing to find out their risks ...
O Brasileiro Raphinha vem tendo uma ótima temporada com as cores do Barcelona ao longo de todo o ano de 2024. Ele se valorizou no mercado e acabou se tornando um dos principais alvos de vários times ...
MONDAY, Dec. 16, 2024 (HealthDay News) -- Risk-reducing mastectomy (RRM) and salpingo-oophorectomy (RRSO) are both associated with significant improvements in outcomes among young BRCA carriers with ...
Liverpool are reported to have initiated contact with the agents of Raphinha over a high-profile move to bring the talismanic Barcelona star back to the Premier League – and what that may mean ...
Eles acreditam que podem se beneficiar da chegada do atleta em janeiro de 2025. Arsenal volta a tentar Raphinha As informações divulgadas pelo portal TBR Football dão conta de que o Arsenal está ...
Foi em 2022 que, ao se destacar pelo Leeds United, da Inglaterra, Raphinha chamou a atenção do gigante Barcelona, que não mediu esforços para contratá-lo. Pois não é que a temporada 2024/25 ...
Raphinha foi, mais uma vez, o destaque do Barcelona na partida de LaLiga realizada neste domingo (15), contra o Leganés. O problema é que o Barça perdeu por 1 a 0, com um gol de Sérgio González logo ...
Liverpool are among the Premier League clubs who have reportedly directly told Barcelona they remain interested in Raphinha if the La Liga giants need to ‘raise funds’. Raphinha has been one ...
Their efficacy in other malignancies is upcoming. Our case demonstrates the effectiveness of PARPi therapy in BRCA2-mutant uLMS. uLMS is an aggressive mesenchymal malignancy notorious for recurrence ...